|EU fines pharmaceutical giants $22 million||| Print ||
|Written by Associated Press|
|Tuesday, 10 December 2013 10:47|
AMSTERDAM (AP) — The European Commission has fined pharmaceuticals giants Johnson & Johnson and Novartis a combined $22 million for colluding to delay the entrance of a cheap generic form of a pain killer to the Dutch market.
In a statement, the Commission's antitrust chief, Joaquin Almunia, said the two companies "shockingly deprived patients in the Netherlands, including people suffering from cancer, from access to a cheaper version of this medicine."
The Commission found that after Johnson & Johnson's patent on a patch containing the drug Fentanyl expired in 2005, it paid Novartis to delay launching a generic version. The delay lasted 17 months, and was more profitable for both companies than competing honestly would have been.
J&J's fine was 10.7 million euros ($14.7 million), and Novartis' was 5.5 million euros.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
|Last Updated on Tuesday, 10 December 2013 15:45|
Front Page Stories
|Perrysburg Twp. Man Sentenced to 22 Years for Rape
07/24/2014 | Sentinel-Tribune Staff
A Perrysburg Township man was senteced to more than 22 years in prison after being found guilty Thur [ ... ]
|Vigil set for BGSU student|
07/24/2014 | Associated Press
CLEVELAND (AP) — A vigil for a Bowling Green State University student who was found dead in Lorain [ ... ]